Posts Tagged ‘EECP’

EECP, ECP – Coronary Artery Disease Treatment

June 14th, 2011

Enhanced External Counter Pulsation (EECP) - Best Alternative to Bypass Surgery

Major developments have overtaken the field of medicinal science in the past two decades. Innovative and advanced technology machines have been invented in various medical fields where it has now become possible to treat even the most complex diseases easily without the need to perform complicated surgeries and operations for the treatment. One of the best examples for this is the EECP or ECP machine. EECP or Enhanced External Counter Pulsation machine is modern equipment designed in USA and approved by USDFA for treatment of heart disease arteries. It increases blood flow to the diseased arteries by 200% and opens up collaterals thereby relieving the chest pain and difficulty in breathing. Using these machines EECP therapy is provided to the individuals with angina, heart failure or cardiomyopathy in order to diminish their symptoms, improve functional capacity and quality of life. This EECP therapy is slowly gaining popularity worldwide and is already available in some of the most advanced and popular medical cardiac centers like Texas Heart Institute, JKF Medical Center Atlantis, John Hopkins Medical Center etc as a non-surgical, out-patient therapy for angina, coronary artery disease, high blood pressure, and other conditions involving poor circulation.

EECP treatment is the best alternative for those who cannot afford for heart bypass surgery or angioplasty, who are unfit for the surgery because of other diseases, patients who already had bypass surgery and whose stents have got blocked again. In this therapy patient’s legs, thighs and buttocks are cuffed in rubber bladders and are connected to telemetry monitors that monitor their heart rate and rhythm. As the ECP machine starts cuffs are timed to inflate and deflate as the pressure waves are sent to the bladders synchronized with the heart beats. With this inflation and deflation procedure the collapsed collaterals are reopened and the blood is pumped into zones deprived of blood. The ultimate results of this therapy can be seen in form of reduced complaints for chest pain, breathing difficulty, patient will be able to walk longer distances without onset of chest pain and will not require taking sub lingual nitrite tablets as earlier. As compared to the risky and dangerous bypass surgery, EECP is safer and easier way of getting rid of heart problems because it involves no surgery, drugs or needles. It carries no risk, is comfortable. It just feels like a deep muscle massage to the legs and the patient is completely relaxed during the process. It is normally administered in an outpatient setting and therefore is also affordable than surgery. So why not opt for EECP than a bypass surgery for heart problems.

Summarizing Results of Randomized Controlled Studies In EECP Therapy

May 18th, 2011

Since 1992, there have been more than 150 articles published in various medical journals, most of them peer-reviewed, documenting the clinical outcomes and mechanisms of action of Enhanced External Counterpulsation (EECP®) therapy. The most well- known randomized controlled trials (RCTs) were the Multicenter Study of Enhanced External Counterpulsation (MUST-EECP): Effect of EECP on Exercise-Induced Myocardial Ischemia and Anginal Episodes in the treatment of patients with angina pectoris and the Prospective Evaluation of Enhanced External Counterpulsation in Congestive Heart Failure (PEECH) Trial. There also have been a number of lesser known RCTs demonstrating the mechanisms of action of EECP® Therapy, some with correlation to clinical outcomes. Even though most of these smaller studies had limited numbers of patients, these RCTs illustrated the effects of EECP® Therapy were sufficiently different from the control group and that their measured endpoints did not have to rely on a large number of patients to demonstrate clinical significance. The eight RCTs listed below not only provided clinical evidence on the effectiveness of EECP® Therapy in improving the functions and Quality of life of patients suffering from coronary artery disease (CAD), they also formed our basic understanding on the mechanisms of action of EECP® Therapy in promoting coronary collateral circulation through angiogenesis, reducing inflammatory reactivity and improving endothelial function in controlling vascular tone and neurohormonal activities.

Please see the complete accompanying chart of the results here: http://www.vasomedical.com/newsletter/Results_Of_Randomized_Control_Studies_in_EECP.pdf

See the full EECP Therapy Newsletter Volume 3, Issue 1 Here: http://www.vasomedical.com/newsletter/Vol3_Issue1.pdf

 

The Cost Effectiveness Of Enhanced External Counterpulsation (EECP?) Therapy

May 6th, 2011

Approximately 6.8 million people in the United States suffer from angina, with 400,000 new cases diagnosed annually, and 80,000-100,000 patients are refractory and suffer from angina or angina equivalent symptoms.

The Centers for Medicare and Medicaid Services (CMS) and many other third-party insurance payers provide coverage for patients who have been diagnosed with disabling angina (Class III or Class IV, Canadian Cardiovascular Society or equivalent classification) who, in the opinion of a cardiologist or cardiothoracic surgeon, are not readily amenable to surgical intervention, such as PCI or cardiac bypass because:

1. Their condition is inoperable, or at high risk of operative complications or post-operative failure,
2. Their coronary anatomy is not readily amenable to such procedures; or
3. They have co-morbid states, which create excessive risk.

 

There are 5 million patients in the United States and approximately 22 million worldwide suffering from heart failure. It is the leading cause of hospitalizations in patients over the age of 65, and is one of the largest burdens on the U.S. healthcare system, costing in excess of billion annually.

EECP® therapy offers an opportunity to redefine the standard of care in how this group of patients is treated and has been demonstrated to reduce both emergency room (ER) visits and hospitalizations in heart failure patients with left ventricular dysfunction by 86% and 83% respectively, from 1.4 to 0.2 ER visits and 2.4 to 0.4 hospitalizations per patient per year.

The EECP® therapy system, a non-invasive outpatient therapy for the treatment of diseases of the cardiovascular system, serves to increase circulation in areas of the heart with less than adequate blood supply and helps to restore systemic vascular function; increases blood flow and oxygen supply to the heart muscle and other organs, and decreases the heart’s workload and reduces oxygen demand; and improves function of the endothelium, the lining of blood vessels throughout the body, lessening resistance to blood flow. EECP® Therapy treats stable or unstable angina, congestive heart failure, acute myocardial infarction, and cardiogenic shock.

EECP Therapy to treat Chronic Angina

April 5th, 2011

Enhanced External counterpulsation (EECP) is a course of action performed on persons suffering from angina to relieve from pain. The treatment also improves exercise tolerance and decreases the degree of ischemia in a cardiac stress test. It is the treatment that allows the heart to heal without the need of surgery.

Angina is chest pain or discomfort that occurs for an individual when an area of heart muscle doesn’t receive enough oxygen-rich blood. Angina may feel like pressure or squeezing in your chest. This is may be because of narrowing of the coronary arteries as a result of arteriosclerosis. Pain can also be observed at shoulders, arms, neck, jaw, or back. Angina pain may even feel like indigestion.

 

Enhanced external counterpulsation (EECP) may be the best choice for treating angina symptoms when all other options of treatment have failed. In a recent issue of Cardiology, it was reported that EECP works even better in patients who have not yet undergone persistent treatment for angina.

 

The procedure of EECP therapy involves wrapping up of long inflatable cuffs (like blood pressure cuffs) around both of the patient’s legs. The leg cuffs are inflated and deflated with each heartbeat. This is accomplished by means of a computer that triggers off the patient’s ECG so that the cuffs deflate when each heartbeat begins, and inflate when each heartbeat ends. The process will occur in a sequential fashion, so that the blood in the legs is “milked” upwards, toward the heart.

 

This inflation/deflation cycle occurs for about 60 to 80 times per minute during an EECP session.  Sessions last approximately 1 to 2 hours once in a day.  A full course of EECP treatment lasts 7 weeks, with about 35 hours of treatment time. EECP therapy significantly improves most of the patient’s tolerance for angina due to coronary artery disease.

 

EECP treatment procedure is a noninvasive one, which does not include any surgical operations.

There will be no needle pricks, even.  And thus EECP is very low risk. There is even no need to take any special medications before or after the treatment and the patient can go home immediately after the treatment. The most common adverse side effects are skin abrasions, bruising, or blistering due to the inflatable cuffs.  Some people also feel minor pain in their legs and back.

EECP – Enhanced External Counterpulsation

February 21st, 2011

EECP is an enhanced external counterpulsation. It is cost effective, non invasive, non surgical, non pharmaceutical, out patient therapy for Angina, Heart attack and heart failure patients. It is FDA (USA) and NHS (UK) approved.

How is EECP Performed?
During EECP Patient lies on bed of machine. Three or five electrodes are applied to the chest to record a constant ECG. A Plethysmograph is applied to index finger to record a tracing that represents blood pressure and oxygen saturation. Set of 3-4 cuffs is wrapped around the calves, thighs and buttocks. EECP system uses an ECG signal to electronically synchronize inflation and deflation of the cuffs.

What is duration of treatment?
Duration for chronic angina and heart failure patients is 35 hours usually one hour per day, five days a week. Some patients choose a 2-hour per day regimen, which reduces the time of completion of treatment. The duration of treatment and interval of rest will depend on the patient’s condition, how much diastolic augmentation is obtained, tolerance of patient and the indications for application of EECP.

What is Mechanism of EECP?
Clinical studies indicate that EECP treatment may create a ‘natural’ bypass of blocked arteries. There are basically two mechanisms involved in this therapy. When we produce diastolic augmentation, this results in opening of lot of inactive blood vessels in heart which helps in bypass the blocked channels. Moreover, this treatment encourages blood vessels to form new small vessels i.e colletrals. These channels or collaterals may eventually become permanent pathways to the heart muscle that was previously deprived of blood flow and adequate oxygen.

What are indications of EECP?
Angina patients who are not relieved by medicine, patients who dont want to have bypass surgery, patients who are contraindicated for bypass or angioplasty like kidney failure, liver failure, severe COPD cases, Diffuse diabetes disease, very old age, patients of Syndrome X, i.e microvessel disease, ischaemic and dilated cardiomyopathy patients all can go for EECP.

What are contraindications of EECP?
Severe aortic regurgitation and aortic stenosis, deep vein thrombosis, pregnancy, very high blood pressure and severe peripheral vascular disease are contraindications for EECP

Side Effects of EECP
EECP has no side effects except little skin bruises specially when patient is not wearing proper skin pants during treatment. In contrast to angioplasty or bypass, it is completely safe procedure with no major risk to patient.

Benefits to the patient
After EECP, patient can walk longer distance without feeling chest pain or breathlessness. Patient’s quality of life improves remarkably. He can take part in daily activities. Above all, patients medicine also decreases, there is less need to take sub lingual nitrates. After treatment heart failure patients don’t have to take high quantity of diuretics.

EECP results verification.
Before and after treatment we perform ECG, Echocardiography, TMT test and Stress thallium scan. All these tests verify the results of EECP. In ECG there is mark decrease in ST segment depression or other ischaemic changes, there is increase in Ejection fraction in Echo, TMT test shows that patient can walk longer distance without chest pain, and stress thallium test also shows that there is less or no more ischaemia in heart.

What is Cost of EECP?
The charge for EECP is approximately one third that of angioplasty and one sixth the cost of coronary artery bypass surgery. In Pakistan EECP charges are US $ 2400 at Dr. Armughan EECP heart Clinic Sialkot.

Insurance & Medicare Coverage
In USA, over 120 insurers are covering EECP. EECP has been covered locally by Paramount, John Hancock, Senior Sense, Paramount Elite, Workman’s Comp, HMO Health Ohio, Messa, Acordia, Access, Envirosource, EV Benefits, First Health, Harrington Benefits, Fortis, Gallagher Benefits, NGS American, United Health Care, Health Alliance Plan, Medical Mutual, Anthem, most Blue Cross/Blue Shield plans, Aetna, Family Health Plan,and Fountainhead. Pre-authorization is required for FHP, Paramount, Senior Sense, Paramount Elite, and HMO Health Ohio patients. Medicare and Medicaid cover EECP in patients with class 3 or class 4 angina (chest Pain) who are not good candidates for bypass surgery (CABG)